Type Ii Variation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Type Ii Variation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Type Ii Variation Today - Breaking & Trending Today

European Approval Sought for Cilta-cel in Relapsed and Lenalidomide-Refractory Myeloma

Published: May 26, 2023

A Type II variation application seeking the approval of ciltacabtagene autoleucel in adult patients with relapsed and lenalidomide-refractory multiple myeloma has been submitted to the European Medicines Agency.

Source: onclive.com

Related Topics:

Sen ZhuangInternational Myeloma Working GroupEuropean CommissionJanssen Research DevelopmentEuropean Medicines AgencyJanssen Pharmaceutical Companies Of JohnsonLegend Biotech CorporationJanssen ResearchInternational Myeloma WorkingJanssen Pharmaceutical CompaniesCilta CelCiltacabtagene AutoleucelMultiple MyelomaCart Cell TherapyLenalidomide Refractory MyelomaCartitude 4 TrialLeaked DataAsco Annual MeetingType Ii Variation